PharmGen Science Inc (004720) — Tangible Net Worth Ratio
PharmGen Science Inc (004720) has a Tangible Net Worth Ratio of 97.2% as of September 2025. This metric is calculated by deducting intangible assets (₩6.94 Billion) from net assets (₩247.76 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of PharmGen Science Inc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PharmGen Science Inc Tangible Net Worth Ratio (2004–2024)
This chart shows how PharmGen Science Inc's Tangible Net Worth Ratio has changed across 17 annual periods from 2004 to 2024. As of September 2025, the ratio stands at 97.2%, reflecting net assets of ₩247.76 Billion with intangible assets of ₩6.94 Billion KRW. For live market cap and overall valuation, see 004720 market cap.
Annual Tangible Net Worth Ratio for PharmGen Science Inc (2004–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for PharmGen Science Inc from 2004 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore capital reinvestment ratio of PharmGen Science Inc to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.1% | ₩249.43 Billion | ₩7.13 Billion | ₩363.45 Billion | ▼ 0.0 pp |
| 2023 | 97.2% | ₩228.21 Billion | ₩6.42 Billion | ₩335.92 Billion | ▲ +0.2 pp |
| 2022 | 97.0% | ₩207.12 Billion | ₩6.18 Billion | ₩317.39 Billion | ▲ +0.5 pp |
| 2021 | 96.5% | ₩126.93 Billion | ₩4.43 Billion | ₩220.32 Billion | ▼ -1.2 pp |
| 2020 | 97.7% | ₩83.57 Billion | ₩1.94 Billion | ₩135.54 Billion | ▼ -0.6 pp |
| 2019 | 98.2% | ₩56.25 Billion | ₩991.66 Million | ₩100.03 Billion | ▲ +0.1 pp |
| 2018 | 98.2% | ₩56.85 Billion | ₩1.05 Billion | ₩98.19 Billion | ▲ +0.1 pp |
| 2017 | 98.1% | ₩51.05 Billion | ₩994.99 Million | ₩68.48 Billion | ▲ +0.6 pp |
| 2016 | 97.5% | ₩36.41 Billion | ₩913.88 Million | ₩64.30 Billion | ▼ -0.5 pp |
| 2015 | 98.0% | ₩28.66 Billion | ₩582.33 Million | ₩46.45 Billion | ▲ +1.1 pp |
| 2014 | 96.9% | ₩20.12 Billion | ₩623.05 Million | ₩42.04 Billion | ▼ -0.5 pp |
| 2013 | 97.4% | ₩23.83 Billion | ₩618.81 Million | ₩39.33 Billion | ▲ +0.0 pp |
| 2012 | 97.4% | ₩25.90 Billion | ₩681.78 Million | ₩42.61 Billion | ▼ -2.2 pp |
| 2011 | 99.6% | ₩18.69 Billion | ₩75.87 Million | ₩42.82 Billion | ▲ +37.8 pp |
| 2005 | 61.8% | ₩33.07 Billion | ₩12.64 Billion | ₩66.47 Billion | ▲ +27.0 pp |
| 2004 | 34.8% | ₩24.91 Billion | ₩16.25 Billion | ₩49.49 Billion | ▲ +1.4 pp |
| 2004 | 33.3% | ₩25.73 Billion | ₩17.15 Billion | ₩49.90 Billion | — |